Form 483

Laboratorios Liconsa SAU Form 483, 2016-02-12

FDA issued a Form 483 to Laboratorios Liconsa SAU on 2016-02-12 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Laboratorios Liconsa SAU · Azuqueca De Henares, Spain · Issued February 12, 2016

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Feb 2016
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Pratik S Upadhyay

12 Feb 2016
21 CFR 211.192

No written record of investigation

Cited by Pratik S Upadhyay

12 Feb 2016
21 CFR 211.25(a)

GMP Training Frequency

Cited by Pratik S Upadhyay

12 Feb 2016
21 CFR 211.68(b)

Computer control of master formula records

Cited by Pratik S Upadhyay

12 Feb 2016
21 CFR 212.60(g)(3)

Record of all test data

Cited by Pratik S Upadhyay

Inspected site

LLLaboratorios Liconsa SAUAzuqueca De Henares, Spain

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.60(g)(3)Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere